Clinical Trials Directory

Trials / Conditions / Immune Thrombocytopenic Purpura (ITP)

Immune Thrombocytopenic Purpura (ITP)

11 registered clinical trials studyying Immune Thrombocytopenic Purpura (ITP) — 4 currently recruiting.

StatusTrialSponsorPhase
RecruitingA Study of Efgartigimod IV in Participants From 12 Years to Less Than 18 Years of Age With Chronic Immune Thro
NCT07194850
argenxPhase 2 / Phase 3
RecruitingA Follow-up Study of Mezagitamab in Adults With Chronic Primary Immune Thrombocytopenia
NCT06948318
TakedaPhase 3
Not Yet RecruitingValidation of the EQ-5D-Y-3L and EQ-5D-Y-5L for Paediatric Patients in China
NCT06873672
RenJi Hospital—
RecruitingA Study of Mezagitamab in Adults With Chronic Primary Immune Thrombocytopenia
NCT06722235
TakedaPhase 3
TerminatedSafety and Tolerability of M254 in Healthy Volunteers and Immune Thrombocytopenic Purpura (ITP) Patients
NCT03866577
Momenta Pharmaceuticals, Inc.Phase 1 / Phase 2
CompletedA Study to Assess the Ability of Eltrombopag to Induce Sustained Response Off Treatment in Subjects With ITP
NCT03524612
Novartis PharmaceuticalsPhase 2
UnknownAssociation of FcγRIIIA Polymorphism and THPO Expression With Response to Eltrombopag in Refractory ITP Patien
NCT02877212
National Institute of Blood and Marrow Transplant (NIBMT), PakistanPhase 3
CompletedClinical Trial of Rituximab in Children and Adolescents With Chronic Idiopathic Thrombocytopenic Purpura (ITP)
NCT01713738
Neufeld, Ellis J, MD, PhDPhase 1 / Phase 2
CompletedEfficacy and Safety Study of a 10% Triple Virally Reduced Intravenous Immune Globulin Solution in Adult Subjec
NCT00162006
Baxalta now part of ShirePhase 2
CompletedSafety and Efficacy Study of a 10% Intravenous Immune Globulin Solution in Subjects With Primary Immunodeficie
NCT00157079
Baxalta now part of ShirePhase 3
CompletedA Phase I Study of Recombinant Human CD4 Immunoglobulin G (rCD4-lgG) in Patients With HIV-Associated Immune Th
NCT00002250
Genentech, Inc.Phase 1